Should I Buy Summit Therapeutics (SMMT)? Finance YouTuber Analysis
VERDICT: BUY 0/100
Get weekly updates on this stock
“The YouTuber sees Summit Therapeutics as a speculative buy due to its promising cancer drug for non-small cell lung cancer, which has shown high…”
Financials
Reported figures · last 5 yearsCall record — SMMT
1 CALLS · 1 BUY / 0 SELL / 0 WATCHCreate a free account to see every call — who, when, at what price.
Each call is dated, linked to the source video, and graded. Free accounts see the full record.
FAQ
Should I buy Summit Therapeutics?
1 finance YouTubers analysed Summit Therapeutics with qualified reasoning — consensus: Buy, average analysis quality 60/100. This is not financial advice; review the individual analyses and sources above.
Are finance YouTubers bullish or bearish on Summit Therapeutics?
Among the channels covering Summit Therapeutics, 1 are buying and 0 are selling or avoiding — overall Buy.
How do you decide what to include for Summit Therapeutics?
Only qualified analyses count: a clear buy/sell stance on Summit Therapeutics with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.